Evidence map›Paper›PMID 25605379›Full record

ArticleMethods in enzymology2015

Ligand-dependent exponential amplification of self-replicating RNA enzymes.

Charles Olea, Gerald F Joyce

Abstract read
In one paragraph

Article in Methods in enzymology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Charles OleaDepartment of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
Gerald F JoyceDepartment of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, USA. Electronic address: gjoyce@scripps.edu.
Scripps Research Institute · US

Funding

Ligand-Dependent Exponential Amplification of RNAR01GM065130 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI JOYCE, GERALD F · 2002 to 2015
$4.1M
Real-time detection of cancer biomarkers using a self-sustained aptazymeF32CA165430 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI OLEA, CHARLES · 2011 to 2013
$155k
NCI NIH HHS F32 CA165430NCI NIH HHS F32CA165430NIGMS NIH HHS GM065130NIGMS NIH HHS R01 GM065130
6 · The paper itself

Abstract

A general analytical method for the detection of target ligands has been developed, based on a special class of self-replicating aptazymes. These "autocatalytic aptazymes" are generated by linking an aptamer domain to the catalytic domain of a self-replicating RNA enzyme. Ligand-dependent self-replication of RNA proceeds in a self-sustained manner, undergoing exponential amplification at a constant temperature without the assistance of any proteins or other biological materials. The rate of exponential amplification is dependent on the concentration of the ligand, thus enabling quantitative ligand detection. This system has the potential to detect any ligand that can be recognized by an aptamer, including small molecules and proteins. The instability of RNA in biological samples due to the presence of ribonucleases can be overcome by employing the enantiomeric L-RNA form of the self-replicating enzyme. Methods for real-time fluorescence monitoring over the course of exponential amplification are currently being developed.

Indexed as

Nucleic Acid ConformationRNA, CatalyticRNA, CatalyticAptamerAptazymeExponential amplificationLigand detectionL-RNASelf-replicating RNA

Identifiers

PMID25605379
PMCPMC5103853
OpenAlexW2411085637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.